Thursday, January 8, 2009
7:26 AM
Email this
-
Wyeth (WYE) is in talks to buy Dutch vaccine maker Crucell (CRXL), part of its efforts to gain market share in one of the fastest growing parts of the industry. Sources say a deal valuing Crucell at over €1B ($1.35B) could be reached as early as next week.